Group 1 - The company has decided to change its registered capital and abolish the supervisory board, transferring its powers to the audit committee under the board of directors, which is in compliance with relevant laws and regulations [1][3] - The supervisory board unanimously agreed to the proposal, which aims to improve the corporate governance structure and better meet the company's operational needs [1][2] - The specific details of the changes were disclosed on the Shanghai Stock Exchange website [1] Group 2 - The company held its 13th meeting of the third board of directors on October 23, 2025, where it approved the appointment of Hu Yuanyuan as a member of the Strategy and ESG Committee [4][6] - The composition of the Strategy and ESG Committee after the appointment includes Fang Yongsheng (Chairman), Wang Guoqiang, Gao Guangxia, and Hu Yuanyuan [4] Group 3 - The company has scheduled its second extraordinary general meeting of shareholders for November 11, 2025, at 13:30 [7][8] - The meeting will be held at the company's conference room located at 837 Yaowang Avenue, Taizhou, Jiangsu Province [8] Group 4 - The company plans to conduct charitable donations in 2025, with a total amount not exceeding RMB 1.5 million, aimed at fulfilling its social responsibilities [27][28] - The donations will include cash and physical assets, and the management is authorized to handle all related matters [28][29] Group 5 - The company appointed Tu Xiaobao as the vice president, effective from the date of the board's approval until the end of the current board's term [31][32] - Tu Xiaobao has extensive experience in the company and meets the qualifications required for the position [31][33]
江苏硕世生物科技股份有限公司